Answers are grounded in this paper and cite their sources.
Lispro administered by QS-M needle-free injector results in earlier and higher insulin exposure than conventional pen, and a greater early glucose-lowering effect with similar overall potency.
No takes yet. Share an insight, caveat, or question.
Hu et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: